CD8A and neoplasm: Although patterns of immune evasion and evolution as key determinants of immunogenicity correlated with the CD8+ T cell densities, the analysis of a single-cell population is insufficient for immunotherapy prediction and also demands for novel biomarker development, such as, e.g., cell-free tumor DNA.